<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Phosphatidylcholines (PCs) is_biomarker_for Colorectal Carcinoma — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Phosphatidylcholines (PCs)</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>Colorectal Carcinoma</strong>
</div>
<div class="entity-id">CHEBI:16110 &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:20%;--color:#ff7f0e"></div>
<div class="stat-row">
  <span>Class: Replicated (2.0)</span>
  <span>Replicated: 3 papers</span>
  <span>Score: 39.68<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 4.00 (Replicated, 3 papers)<br>Score from 30 citations: <strong>39.68</strong><br><span style="color:#888">11&times; extends (+27.63) &middot; 17&times; supports (+12.00) &middot; 1&times; contradicts (-0.25) &middot; 1&times; applies (+0.30)</span><br>Neighbourhood: 42.58</div>


<p class="section-label">EVIDENCE CHAIN &middot; 3 sources</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#ff7f0e" title="Replicated"></span><span>Replicated</span><a href="https://doi.org/10.3892/mmr.2015.4289">10.3892/mmr.2015.4289</a></div>
<div class="evidence-row"><span class="evidence-dot" style="background:#ff7f0e" title="Replicated"></span><span>Replicated</span><a href="https://doi.org/10.1016/j.jpba.2023.115582">10.1016/j.jpba.2023.115582</a></div>
<div class="evidence-row"><span class="evidence-dot" style="background:#ff7f0e" title="Replicated"></span><span>Replicated</span><a href="https://doi.org/10.3390/ijms25147722">10.3390/ijms25147722</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 30 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>17</span><span class="cite-subtotal">&middot; +12.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolite peak count (VOC richness) — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/036d3a84ec387294.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">VOC profile — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/772e5e5d5e7e31c1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,3,4-trimethylhexane — decreases → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/c156b7aeb268bbfa.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,4-dimethylhept-1-ene — increases → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/acb7845754617579.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,3,4-trimethylhexane — is_metabolite_of → lipid peroxidation</span><span class="cite-claim-weight">+0.50</span><a href="../claim/a3d48c01fcd3dfbf.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,4-dimethylhept-1-ene — is_metabolite_of → lipid peroxidation</span><span class="cite-claim-weight">+0.50</span><a href="../claim/8b2a38e165b645fb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC(18:0/18:1) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/8477d23a810774c9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PE(18:0/20:4) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bb50e0c283aa54f1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bb313c103d3f8b81.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lipogenic phenotype (upregulated lipogenesis) — correlates_with → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/fc1a0b488fe38bb6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">odd-chain fatty acyl-containing triacylglycerols — distinguishes → colon cancer</span><span class="cite-claim-weight">+4.00</span><a href="../claim/55b1b2efbdcd8b5d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine — distinguishes → FOLFOXIRI-resistant SW620 colorectal cancer cells</span><span class="cite-claim-weight">+0.50</span><a href="../claim/d3889998afcb28f1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Cholesteryl esters — distinguishes → FOLFOXIRI-resistant SW620 colorectal cancer cells</span><span class="cite-claim-weight">+0.50</span><a href="../claim/a90a4cff6ebc8100.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Hexosylceramide — distinguishes → FOLFOXIRI-resistant HCT116, LS174T, and DLD1 colorectal cancer cells</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bcc4fe98268a8c95.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sphingomyelin — distinguishes → FOLFOXIRI-resistant HCT116, LS174T, and DLD1 colorectal cancer cells</span><span class="cite-claim-weight">+0.50</span><a href="../claim/6816f462d85912b3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">FOLFOXIRI chronic exposure — increases → Sphingomyelin</span><span class="cite-claim-weight">+0.50</span><a href="../claim/efb08c16669d0118.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lysophosphatidylcholine — decreases → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/d990622cef9e876f.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:6px"></span><span>1</span><span class="cite-subtotal">&middot; -0.25</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">FOLFOXIRI chronic exposure — increases → Hexosylceramide</span><span class="cite-claim-weight">-0.25</span><a href="../claim/cf527ab0501fe579.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:65px"></span><span>11</span><span class="cite-subtotal">&middot; +27.63</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">ceramides — is_biomarker_for → colorectal adenocarcinoma tissue</span><span class="cite-claim-weight">+5.57</span><a href="../claim/fbddabef2bccbbf8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Fatty acids — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+7.20</span><a href="../claim/6ad1651b9e44eeed.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine (PC 16:0/18:1) — distinguishes → pMMR vs dMMR colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/7cd9963dbde9d220.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,3,4-trimethylhexane — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/e3304c000f3be0a4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,4-dimethylhept-1-ene — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/74ad2fb01fce147d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Phospholipid profile — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+4.80</span><a href="../claim/6731a61527be13c8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LysoPC) — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/da12e4ff94bff4d9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylglycerol — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5ccf3ca6907853fc.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sterol esters — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/2ddf49d0d1512692.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">sphingolipids — is_biomarker_for → colon cancer</span><span class="cite-claim-weight">+4.80</span><a href="../claim/19f874501acc5676.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Triacylglycerols — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/91c7e117aa28d92a.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:6px"></span><span>1</span><span class="cite-subtotal">&middot; +0.30</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylethanolamine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.30</span><a href="../claim/367abe64d5d037b2.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>4d490d6332335a4a</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/CHEBI:16110">CHEBI:16110</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
